Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC60H81N5O9 |
InChIKeyRLQDLUGWXIZLOW-RYGGPLERSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Japan | 15 Mar 2018 | |
Neoplasms | Preclinical | Japan | 15 Mar 2018 |